Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986 Nov; 68(5):1114-8.
View in:
PubMed
subject areas
Anemia, Aplastic
Body Weight
Bone Marrow Transplantation
Cyclophosphamide
Dose-Response Relationship, Drug
Drug Administration Schedule
Heart Failure
HLA Antigens
Humans
Immunologic Deficiency Syndromes
Retrospective Studies
Risk
Surface Properties
Wiskott-Aldrich Syndrome
authors with profiles
Joseph Harry Antin, M.D.
Eva Catharina Guinan, M.D.